AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $428,000 | -37.7% | 85,000 | 0.0% | 0.00% | -42.9% |
| Q2 2020 | $687,000 | +329.4% | 85,000 | +37.1% | 0.01% | +250.0% |
| Q4 2018 | $160,000 | -41.2% | 62,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $272,000 | -28.4% | 62,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $380,000 | -15.9% | 62,000 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $452,000 | -11.0% | 62,000 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $508,000 | -56.4% | 62,000 | -44.1% | 0.01% | -55.0% |
| Q3 2017 | $1,166,000 | -4.7% | 111,000 | 0.0% | 0.02% | -13.0% |
| Q2 2017 | $1,224,000 | +13.9% | 111,000 | 0.0% | 0.02% | +9.5% |
| Q1 2017 | $1,075,000 | – | 111,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |